April 2018 Price Concessions/NCSO – 2nd update


April 2018 Price Concessions/NCSO – 2nd update

April 24, 2018

Department of Health and Social Care (DHSC) has today granted the following list of price concessions:

Drug Pack size Price Concession
Aripiprazole 10mg tablets 28 £3.05
Bicalutamide 150mg tablets 28 £16.94
Co-codamol 30mg/500mg capsules 100 £4.50
Glimepiride 1mg tablets 30 £2.22
Irbesartan 150mg tablets 28 £5.12
Irbesartan 75mg tablets 28 £2.40
Mirtazapine 15mg orodispersible tablets 30 £1.50
Mirtazapine 45mg orodispersible tablets 30 £2.00
Oxybutynin 5mg tablets 56 £1.87
Perindopril erbumine 2mg tablets 30 £4.13
Perindopril erbumine 4mg tablets 30 £3.30
Perindopril erbumine 8mg tablets 30 £5.85
Pioglitazone 30mg tablets 28 £14.85
Topiramate 50mg tablets 60 £9.50
Venlafaxine 75mg tablets 56 £5.68

DHSC previously (19.04.2018) granted the following price concessions:

Drug Pack size Price Concession
Amitriptyline 50mg tablets 28 £2.88
Aripiprazole 5mg tablets 28 £2.85
Aripiprazole 15mg tablets 28 £3.22
Bicalutamide 50mg tablets 28 £17.24
Chlorpromazine 50mg tablets 28 £32.47
Lacidipine 2mg tablets 28 £2.95
Lansoprazole 15mg orodispersible tablets 28 £2.98
Oxybutynin 2.5mg tablets 56 £1.11
Phenoxymethylpenicillin 125mg/5ml oral solution 100ml £5.96
Phenoxymethylpenicillin 250mg/5ml oral solution 100ml £7.43
Ramipril 2.5mg tablets 28 £1.04
Trimethoprim 200mg tablets 6 £0.40
Trimethoprim 50mg/5ml oral suspension sugar free 100ml £3.75

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated April 2018 Drug Tariff price.  Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.
Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.


Posted in: ,

More Latest News >

Ask PSNC: Quality Payments FAQs

The team at PSNC has received a number of queries on the Quality Payments Scheme. Below are some of the questions asked in recent weeks....